Horizon Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

11.01.23	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
10.01.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAFE, BNFT, HZNP (PR Newswire)
10.01.23	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
09.01.23	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
06.01.23	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
05.01.23	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
04.01.23	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
03.01.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APEN, HZNP, SESN (PR Newswire)
03.01.23	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
30.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
29.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
28.12.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HZNP, MLVF, TCFC, SHBI (PR Newswire)
28.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
27.12.22	The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
23.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
22.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
21.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
20.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
20.12.22	Horizon Says UPLIZNA Approved By Brazilian Health Regulatory Agency As Monotherapy For NMOSD (RTTNews)
20.12.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAR, HZNP, COUP, USER (PR Newswire)
19.12.22	The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
16.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
15.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
14.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
13.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
12.12.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HZNP, COUP, WEBR (PR Newswire)
12.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
12.12.22	Horizon Therapeutics Stock Soars On Acquisition By Amgen (RTTNews)
12.12.22	Sanofi Says Doesn't Intend To Make Offer For Horizon; But Amgen Reportedly In Advanced Talks (RTTNews)
09.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
08.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
07.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
06.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
05.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
02.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
01.12.22	Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc (EQS Group)
30.11.22	Pre-market Movers: HZNP, RVP, SFR, TMDX, CRWD… (RTTNews)
23.11.22	Xeris Biopharma Inks Research Collaboration With Horizon Therapeutics To Develop Teprotumumab (RTTNews)
12.09.22	Horizon Says Phase 2 Trial Of Dazodalibep To Treat Sjögren's Syndrome Met Primary Endpoint (RTTNews)
09.09.22	Horizon Therapeutics To Buyback Up To $500 Mln Of Ordinary Shares (RTTNews)
15.08.22	Horizon Enters Option Agreement With Q32 Bio To Advance ADX-914 For Autoimmune Diseases (RTTNews)
08.07.22	Horizon Therapeutics: FDA Approves Expanded Labeling For KRYSTEXXA With Methotrexate (RTTNews)
28.06.22	Biotech Stocks Facing FDA Decision In July 2022 (RTTNews)
15.06.22	Horizon Therapeutics Submits Regulatory Filing For UPLIZNA To Treat NMOSD In Brazil (RTTNews)
03.05.22	Horizon Therapeutics: Dazodalibep Phase 2 Rheumatoid Arthritis Trial Meets Primary Endpoint (RTTNews)
02.05.22	EU Approves Horizon Therapeutics' Uplizna For Treatment Of Neuromyelitis Optica Spectrum Disorder (RTTNews)
11.01.22	ACELYRIN Appoints Melanie Gloria as Chief Operating Officer (PR Newswire)
16.12.21	Why Alpine Immune Sciences Is Rising In Pre-market? (RTTNews)
22.11.21	Horizon : New Analysis Supports Efficacy Of UPLIZNA For Neuromyelitis Optica Spectrum Disorder (RTTNews)
23.09.21	Horizon Therapeutics: UPLIZNA Shows Durable Efficacy In African Americans With NMOSD (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Horizon Therapeutics PLC

Aktien Top/Flop

Meistgelesene Nachrichten